P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS <50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000970828.73617.2e |
| _version_ | 1797280873003876352 |
|---|---|
| author | Efstathios Kastritis Meral Beksac Sorina Badelita Eirini Katodritou Jelena Bila Emmanouil Spanoudakis Güldane Cengiz Seval Zorica Cvetkovic Daniel Coriu Marko Mitrovic Carmen Saguna Dimitra Dalampira Anca Bojan Josip Batinic Samo Zver Margarita Guenova Arben Ivanaj Maria Gavriatopoulou Evangelos Terpos Meletios A. Dimopoulos |
| author_facet | Efstathios Kastritis Meral Beksac Sorina Badelita Eirini Katodritou Jelena Bila Emmanouil Spanoudakis Güldane Cengiz Seval Zorica Cvetkovic Daniel Coriu Marko Mitrovic Carmen Saguna Dimitra Dalampira Anca Bojan Josip Batinic Samo Zver Margarita Guenova Arben Ivanaj Maria Gavriatopoulou Evangelos Terpos Meletios A. Dimopoulos |
| author_sort | Efstathios Kastritis |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:46:30Z |
| format | Article |
| id | doaj.art-b8c2d9541e744f6099aa6793ae6f6103 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:46:30Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-b8c2d9541e744f6099aa6793ae6f61032024-03-03T06:25:15ZengWileyHemaSphere2572-92412023-08-017e736172e10.1097/01.HS9.0000970828.73617.2e202308003-00881P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS <50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUPEfstathios Kastritis0Meral Beksac1Sorina Badelita2Eirini Katodritou3Jelena Bila4Emmanouil Spanoudakis5Güldane Cengiz Seval6Zorica Cvetkovic7Daniel Coriu8Marko Mitrovic9Carmen Saguna10Dimitra Dalampira11Anca Bojan12Josip Batinic13Samo Zver14Margarita Guenova15Arben Ivanaj16Maria Gavriatopoulou17Evangelos Terpos18Meletios A. Dimopoulos191 National and Kapodistrian University of Athens, Department of Clinical Therapeutics, Athens, Greece2 Ankara University School of Medicine, Department of Hematology and BMT Unit, Ankara, Turkey3 Fundeni Clinical Institute, Department of Hematology, Bucharest, Romania4 Theageneion Cancer Hospital, Department of Hematology, Thessaloniki, Greece5 University Clinical Center of Serbia, Clinic of Hematology,, Belgrade, Serbia6 Democritus University of Thrace, Medical School, Department of Hematology, Alexandroupolis, Greece2 Ankara University School of Medicine, Department of Hematology and BMT Unit, Ankara, Turkey7 Clinical Hospital Center Zemun, University of Belgrade, Belgrade, Serbia8 Carol Davila University of Medicine and Pharmacy, Department of Hematology, Bucharest, Romania5 University Clinical Center of Serbia, Clinic of Hematology,, Belgrade, Serbia8 Carol Davila University of Medicine and Pharmacy, Department of Hematology, Bucharest, Romania4 Theageneion Cancer Hospital, Department of Hematology, Thessaloniki, Greece9 Iuliu Hațieganu University of Medicine and Pharmacy, Department of Hematology, Cluj-Napoca, Romania10 University Hospital Centre Zagreb, Department of Hematology, Zagreb, Croatia11 University Medical Centre Ljubljana, Department of Hematology,, Ljubljana, Slovenia12 National Specialised Hospital for Active Treatment of Haematological Diseases, Laboratory of Haematopathology and Immunology,, Sofia, Bulgaria13 UMT of Tirana, Department of Haematology, Tirana, Albania1 National and Kapodistrian University of Athens, Department of Clinical Therapeutics, Athens, Greece1 National and Kapodistrian University of Athens, Department of Clinical Therapeutics, Athens, Greece1 National and Kapodistrian University of Athens, Department of Clinical Therapeutics, Athens, Greecehttp://journals.lww.com/10.1097/01.HS9.0000970828.73617.2e |
| spellingShingle | Efstathios Kastritis Meral Beksac Sorina Badelita Eirini Katodritou Jelena Bila Emmanouil Spanoudakis Güldane Cengiz Seval Zorica Cvetkovic Daniel Coriu Marko Mitrovic Carmen Saguna Dimitra Dalampira Anca Bojan Josip Batinic Samo Zver Margarita Guenova Arben Ivanaj Maria Gavriatopoulou Evangelos Terpos Meletios A. Dimopoulos P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS <50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP HemaSphere |
| title | P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS <50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP |
| title_full | P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS <50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP |
| title_fullStr | P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS <50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP |
| title_full_unstemmed | P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS <50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP |
| title_short | P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS <50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP |
| title_sort | p981 disease characteristics and treatment outcomes of myeloma patients 50 years of age an analysis of the balkan myeloma study group |
| url | http://journals.lww.com/10.1097/01.HS9.0000970828.73617.2e |
| work_keys_str_mv | AT efstathioskastritis p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT meralbeksac p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT sorinabadelita p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT eirinikatodritou p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT jelenabila p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT emmanouilspanoudakis p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT guldanecengizseval p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT zoricacvetkovic p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT danielcoriu p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT markomitrovic p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT carmensaguna p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT dimitradalampira p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT ancabojan p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT josipbatinic p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT samozver p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT margaritaguenova p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT arbenivanaj p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT mariagavriatopoulou p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT evangelosterpos p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup AT meletiosadimopoulos p981diseasecharacteristicsandtreatmentoutcomesofmyelomapatients50yearsofageananalysisofthebalkanmyelomastudygroup |